Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1043-1053

  Legge, Kevin L ^a   Min, Booki ^a   Potter, Nicholas T ^b   Zaghouani, Habib ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN; MYELIN BASIC PROTEIN; PROTEOLIPID; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CELL MATURATION; DOWN REGULATION; ENDOCYTOSIS; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; T LYMPHOCYTE ACTIVATION;

ANIMALS; DNA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOCYTOSIS; IMMUNOGLOBULINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MYELIN PROTEOLIPID PROTEIN; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; SPLEEN; T-LYMPHOCYTES;

EID: 0030938568     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1043     Document Type: Article

References (49)

1. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93-126.
2. Sebzda, E., V.A. Wallace, J. Mayer, R.S.M. Yeung, T.W. Mak, and P.S. Ohashi. 1994. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science (Wash. DC). 263:1615-1618.
3. Ashton-Rickardt, P.G., A. Bandeira, J.R. Delaney, L. Van Kaer, H.-P. Pircher, R.M. Zinkernagel, and S. Tonegawa. 1994. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 76:651-663.
4. Hsu, B.L., B.D. Evavold, and P.M. Allen. 1995. Modulation of T cell development by an endogenous altered peptide ligand. J. Exp. Med. 181:805-810.
5. Cibotti, R., J.M. Kanellopoulos, J.-P. Cabaniols, O. Halle-Panenko, K. Kosmatopoulos, E. Sercarz, and P. Kourilsky. 1992. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl. Acad. Sci. USA. 89:416-420.
6. Mamula, M.J. 1993. The inability to process a self-peptide allows autoreactive T cells to escape self-tolerance. J. Exp. Med. 177:567-571.
7. Liu, G.Y., P.J. Fairchild, R.M. Smith, J.R. Prowle, D. Kioussis, and D.C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
8. Brocke, S., A. Gaur, C. Piercy, A. Gautam, K. Gijbels, C.G. Fathman, and L. Steinman. 1993. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature (Lond.). 365:642-644.
9. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
10. McRae, B.L., C.L. Vanderlugt, M.C. Dal Canto, and S.D. Miller. 1995. Functional evidence for epitope speading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
11. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
12. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
13. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
14. Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Rheumatoid arthritis. Cell. 85:307-310.
15. Martin, R., H.F. McFarland, and D.E. McFarlin. 1992. Immunological aspects of demyelinating disease. Annu. Rev. Immunol. 10:153-187.
16. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1523-1527.
17. β usage. J. Immunol. 148:3776-3782.
18. Zhang, J., S. Markovic-Plese, B. Lacet, J. Raus, H.L. Weiner, and D.A. Hafler. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:973-984.
19. Chou, Y.K., D.N. Bourdette, H. Offner, R. Whithan, R.Y. Wang, G.A. Hashim, and A.A. Vandenbark. 1992. Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis. J. Neuroimmunol. 38:105-113.
20. Evavold, B.D., J. Sloan-Lancaster, and P.M. Allen. 1993. Tickling the TCR: selective T cell functions stimulated by altered peptide ligands. Immunol. Today. 14:602-609.
21. Evavold, B.D., and P.M. Allen. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (Wash. DC). 252:1308-1310.
22. Windhagen, A., C. Scholz, P. Höllsberg, H. Fukaura, A. Sette, and D.A. Hafler. 1995. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity. 2:373-380.
23. De Magistris, M.T., J. Alexander, M. Coggeshall, A. Altman, F.C.A. Gaeta, H.M. Grey, and A. Sette. 1992. Antigen analog-major histocompatibility complexes act as antagonist of the T cell receptor. Cell. 68:625-634.
24. Jameson, S.C., F.R. Carbone, and M.J. Bevan. 1993. Clone-specific T cell receptor antagonist of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177: 1541-1550.
25. Racioppi, L., F. Ronchese, L.A. Matis, and R.N. Germain. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047-1060.
26. Sloan-Lancaster, J., B.D. Evavold, and P.M. Allen. 1993. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature (Lond.). 363:156-159.
27. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Peircy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell et al. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature (Lond.). 379:343-346.
28. Karin, N., D.J. Mitchell, S. Brocke, N. Ling, and L. Steinman. 1994. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor a production. J. Exp. Med. 180:2227-2237.
29. Kuchroo, V.K., J.M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R.A. Sobel, and M.B. Lees. 1994. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 153:3326-3336.
30. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (Lond.). 375:603-606.
31. Valitutti, S., S. Müller, M. Cella, E. Padovan, and A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature (Lond.). 375:148-151.
32. Zanetti, M., F. Rossi, P. Lanza, G. Filaci, R.H. Lee, and R. Billetta. 1992. Theoretical and practical aspects of antigenized antibodies. Immunol. Rev. 130:125-150.
33. Zaghouani, H., Y. Kuzo, H. Kuzo, N. Mann, C. Daian, and C. Bona. 1993. Engineered immunoglobulin molecules as vehicles for T cell epitopes. Int. Rev. Immunol. 10:265-278.
34. Zaghouani, H., R. Steinman, R. Nonacs, H. Shah, W. Gerhard, and C. Bona. 1993. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science (Wash. DC). 259:224-227.
35. Zambidis, E.T., and D.W. Scott. 1996. Epitope-specific tolerance induction with an engineered immunoglobulin. Proc. Natl. Acad. Sci. USA. 93:5019-5024.
36. Brumeanu, T.D, W.J. Swiggard, R.M. Steinman, C. Bona, and H. Zaghouani. 1993. Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus. J. Exp. Med. 178:1795-1799.
37. Greer, J.M., V.K. Kuchroo, R.A. Sobel, and M.B. Lees. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:783-788.
38. k gene segments of A/J Ars-A antibodies: somatic recombination generates the essential arginine at the junction of the variable and joining regions. Proc. Natl. Acad. Sci. USA. 84:1085-1089.
39. Ruthban, G.A., F. Otani, E.C.B. Milner, D.J. Capra, and P.H.W. Tucker. 1988. Molecuar characterization of the A/J J558 family of heavy chain variable region segments. J. Mol. Biol. 202:383-395.
40. Zaghouani, H., M. Krystal, H. Kuzu, T. Moran, H. Shah, Y. Kuzu, J. Schulman, and C. Bona. 1992. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells. J. Immunol. 148:3604-3609.
41. Lees, M., and J.D. Sakura. 1978. Preparation of proteolipids. In Research Methods in Neurochemistry. N. Marks and R. Rodnight, editors. Plenum Press, New York. 345-370.
42. Zaghouani, H., D. Goldstein, H. Shah, S. Anderson, M. Lacroix, G. Dionne, R.C. Kennedy, and C. Bona. 1991. Induction of antibodies to the envelope protein of the human immunodeficiency virus by immunization with monoclonal anti-idio-types. Proc. Natl. Acad. Sci. USA. 88:5645-5649.
43. Zaghouani, H., S.A. Anderson, K.E. Sperber, C. Daian, R.C. Kennedy, L. Mayer, and C. Bona. 1995. Induction of antibodies to the human immunodeficiency virus type 1 by im-munization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc. Natl. Acad. Sci. USA. 92:631-635.
44. Vidal, K., B.L. Hsu, C.B. Williams, and P.M. Allen. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311-1321.
45. Hahn, Y.S., V.L. Braciale, and T.J. Braciale. 1991. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product. J. Exp. Med. 174:733-736.
46. Chimini, G., P. Pala, J. Sire, B.R. Jordan, and J.L. Maryanski. 1989. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. J. Exp. Med. 169:297-303.
47. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by the T cell receptor number and tunable thresholds. Science (Wash. DC). 273:104-106.
48. Lyons, D.S., S.A. Leiberman, J. Hampi, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than do agonist. Immunity. 5:53-61.
49. Nicholson, L.B., J.M. Greer, R.A. Sobel, M.B. Lees, and V.K. Kuchroo. 1996. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:397-405.